Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
GU Cancers 2022
;
Join us for our Post-ASCO 2024 #LungCancer Highlights 📣
🌟 Chaired by Professor Sanjay Popat
Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦
Agenda available soon 📝
REGISTER 👉 https://us06web.zoom.us/webinar/register/4117150940818/WN_77bU3HolRNS0T0MkOrJQOA
#ASCO24
🎥Leonardo Provenzano, MD, from @IstTumori explores machine learning to predict early progression in HR+/HER2- advanced #breastcancer using data from the PALMARES-2 study:
➡️⬅️
@myESMO #ESMOBreast24
Predicting early progression in HR+/HER2- breast cancer with AI models
Leonardo Provenzano, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, examines the use of machine lea...
ow.ly
🎥@elisabettasabet of @IEOufficiale discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer:
➡️https://ow.ly/rOye50RJWy9⬅️
@myESMO #ESMOBreast24
🚨 Don't miss the latest episode of our weekly podcast!
This week we're showcasing highlights from #ESMOBreast24
👂Listen here:
#BreastCancer #BCsm @myESMO @OncoAlert
Key Updates at ESMO Breast 2024 - VJOncology
In today’s episode, we bring you key highlights from ESMO Breast 2024, diving into important discussions surrounding the latest research...
tinyurl.com
May is #SkinCancerAwarenessMonth 📣
According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸
Check out our skin cancer channel for the latest news and updates 👉 https://www.vjoncology.com/subject/skin-cancer
GU Cancers 2022
Join us for our Post-ASCO 2024 #LungCancer Highlights 📣
🌟 Chaired by Professor Sanjay Popat
Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦
Agenda available soon 📝
REGISTER 👉 https://us06web.zoom.us/webinar/register/4117150940818/WN_77bU3HolRNS0T0MkOrJQOA
#ASCO24
🎥Leonardo Provenzano, MD, from @IstTumori explores machine learning to predict early progression in HR+/HER2- advanced #breastcancer using data from the PALMARES-2 study:
➡️⬅️
@myESMO #ESMOBreast24
Predicting early progression in HR+/HER2- breast cancer with AI models
Leonardo Provenzano, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, examines the use of machine lea...
ow.ly
🎥@elisabettasabet of @IEOufficiale discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer:
➡️https://ow.ly/rOye50RJWy9⬅️
@myESMO #ESMOBreast24
🚨 Don't miss the latest episode of our weekly podcast!
This week we're showcasing highlights from #ESMOBreast24
👂Listen here:
#BreastCancer #BCsm @myESMO @OncoAlert
Key Updates at ESMO Breast 2024 - VJOncology
In today’s episode, we bring you key highlights from ESMO Breast 2024, diving into important discussions surrounding the latest research...
tinyurl.com
May is #SkinCancerAwarenessMonth 📣
According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸
Check out our skin cancer channel for the latest news and updates 👉 https://www.vjoncology.com/subject/skin-cancer
